FDA Clears Haemonetics’ NexSys PCS Enhancement
Haemonetics’ enhancement of its plasma collection tool, NexSys PCS, earned FDA marketing clearance.
The tool will offer the NexSys PCS device along with the NexLynk DMS donor management software and disposables.
The clearance allows the product to increase the plasma yield per collection.
Haemonetics plans a commercial launch of the tool this summer.